Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
J W H H Dammers a Department of Neurology, Medical
Centre Alkmaar, PO Box 501, 1800 AM Alkmaar, Netherlands, b Department of Neurology,
Academic Medical Centre, University of Amsterdam, PO Box 22700, Amsterdam, Netherlands
Correspondence to: Dr Dammers
J.Dammers{at}mca.alkmaar.nl
Objective:
To assess the effect of a 40 mg
methylprednisolone injection proximal to the carpal tunnel in patients
with the carpal tunnel syndrome.
Design:
Randomised double blind placebo controlled trial.

View larger version (
[in a new window]
Fig 1.
Site for injecting corticosteroid to treat
carpal tunnel syndrome
Setting:
Outpatient neurology clinic in a district general hospital.
Participants:
Patients with symptoms of the carpal
tunnel syndrome for more than 3 months, confirmed by
electrophysiological tests and aged over 18 years.
Intervention:
Injection with 10 mg lignocaine
(lidocaine) or 10 mg lignocaine and 40 mg methylprednisolone.
Non-responders who had received lignocaine received 40 mg
methylprednisolone and 10 mg lignocaine and were followed in
an open study.
Main outcome measures:
Participants were scored as
having improved or not improved. Improved was defined as no symptoms or
minor symptoms requiring no further treatment.
Results:
At 1 month 6 (20%) of 30 patients in
the control group had improved compared with 23 (77%) of 30 patients
the intervention group (difference 57% (95% confidence interval 36%
to 77%)). After 1 year, 2 of 6 improved patients in the control group
did not need a second treatment, compared with 15 of 23 improved
patients in the intervention group (difference 43% (23% to 63%). Of
the 28 non-responders in the control group, 24 (86%) improved after methylprednisolone. Of these 24 patients, 12 needed surgical treatment within one year.
Conclusion:
A single injection with steroids close to the carpal tunnel may result in long term improvement and should be
considered before surgical decompression.
Key messages
Read all Rapid Responses